BDRX institutional holdings
See which institutional managers reported holdings in Biodexa Pharmaceuticals (BDRX), with reported position values, share changes and source 13F filings by quarter.
- 13F holdings for the quarter ending Sep 30, 2026.
Institutional holdings
| Manager | Shares | Share change | Change % | Reported value | Source |
|---|---|---|---|---|---|
| HRT FINANCIAL LP | 71,249 | 71,249 | – | $46.00K | Filing |
| StoneX Group Inc. | 12,499 | 12,499 | – | $8.37K | Filing |
| UBS Group AG | 1,786 | 1,761 | 7044.00% | $1.17K | Filing |
| SBI Securities Co., Ltd. | 19 | -10 | -34.48% | $12.00 | Filing |
| Caitong International Asset Management Co., Ltd | 1 | -4 | -80.00% | $1.00 | Filing |
| JPMORGAN CHASE & CO | 1 | 1 | – | $1.00 | Filing |
| ARMISTICE CAPITAL, LLC | 0 | -14,809 | -100.00% | $0.00 | Filing |
| GAMMA Investing LLC | 0 | -1,203 | -100.00% | $0.00 | Filing |
| Hilton Head Capital Partners, LLC | 0 | -6 | -100.00% | $0.00 | Filing |
| RHUMBLINE ADVISERS | 0 | -3 | -100.00% | $0.00 | Filing |